Virtual Medicinal Product (VMP) - Ubidecarenone 30mg / Magnesium oxide 150mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Ubidecarenone 30mg / Magnesium oxide 150mg tablets | Start Date 27-11-2009 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- Other
Codes
- ATC Code
- n/a
- BNF Codes
-
- BNF code 09110200
| Code | Start Date | End Date |
|---|---|---|
| 16460511000001101 | 27-11-2009 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Magnesium oxide | Based on Ingredient Substance | 150 mg | ||
| Ubidecarenone | Based on Ingredient Substance | 30 mg |
Name
Magnesium oxide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
Name
Ubidecarenone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30
Strength and UOM (Dmr)
Parent Products
-
VTMUbidecarenone + Magnesium oxide
-
VMP(Current) Ubidecarenone 30mg / Magnesium oxide...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 30 tablet |